Qube Research & Technologies (QRT)
TRIL

Qube Research & Technologies (QRT)’s Trillium Therapeutics Inc. TRIL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-24,214
Closed -$344K – 2337
2020
Q3 		$344K Buy
+24,214
New +$241K ﹤0.01% 1179

Other funds holding TRIL

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TRIL Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2020, closing a stake of 24,214 shares — an estimated $344K sold.

Qube Research & Technologies (QRT) first reported a position in TRIL in Q3 2020 and held it in 1 quarter. The position peaked at $344K in Q3 2020. 131 funds tracked by Wall St. Rank hold TRIL as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Trillium Therapeutics Inc. position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 24,214 Trillium Therapeutics Inc. shares in Q4 2020, an estimated $344K.
  • Qube Research & Technologies (QRT) first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Trillium Therapeutics Inc. position peaked at $344K in Q3 2020.
  • 131 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.